US EditionMerck announces $70 billion US manufacturing investment
- On Monday, Merck & Co., Inc. announced a more than $70 billion U.S. investment starting in 2025 and began construction of a $3 billion, 400,000-square-foot facility in Elkton, Virginia.
- Amid the White House's renewed 'Made in America' pharmaceutical initiative, Merck said it will work with the U.S. administration on policy promoting domestic manufacturing and innovation.
- More than 48,000 construction-related jobs are expected by 2029, and the Elkton site will create 500 full-time positions and roughly 8,000 construction jobs.
- The plant will expand U.S. production of vaccines and active pharmaceutical ingredients, adding next-generation therapeutics capacity, Merck & Co., Inc. said.
- The Elkton project is Merck's fourth U.S. build this year, joining other sites in Delaware, North Carolina and Kansas amid Johnson & Johnson's $2B U.S. manufacturing investment.
28 Articles
28 Articles
Merck to add 500 job at Elkton campus: Pharmaceutical giant breaking ground on $3 billion expansion
Pharmaceutical giant Merck & Co. is breaking ground on a $3 billion expansion of its longtime Elkton manufacturing campus, a project state and federal officials say will transform the Shenandoah Valley into a hub for life sciences innovation while adding…
Merck Breaks Ground on $3 Billion Virginia Plant, Advancing $70 Billion US Expansion
Global pharmaceutical manufacturer Merck, also known as MSD outside the United States and Canada, will begin construction of its new $3 billion, 400,000-square-foot facility at the Elkton, Virginia, site. In an Oct. 20 announcement, the company noted that the new Center for Excellence in Pharmaceutical Manufacturing is part of its $70 billion investment plan for manufacturing and research within the United States. “Today is an important mileston…
InsideNoVA.com
Virginia MercuryMerck to invest $3 billion in Elkton expansion, adding up to 500 jobs in Shenandoah Valley
Pharmaceutical giant Merck & Co. is breaking ground on a $3 billion expansion of its longtime Elkton manufacturing campus, a project state and federal officials say will transform the Shenandoah Valley into a hub for life sciences innovation while adding…
Merck Starts Construction Of $3 Bln Manufacturing Facility At Its Elkton, Virginia Site
(RTTNews) - Merck & Co., Inc. (MRK), known as MSD outside of the U.S. and Canada, announced Monday the start of construction for a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility at its Elkton, Virginia, site.
Coverage Details
Bias Distribution
- 63% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
